Targeting mTOR signaling for lung cancer therapy

被引:21
作者
Sun, Shi-Yong
Fu, Haian
Khuri, Fadlo R.
机构
[1] Emory Univ, Sch Med, Winship Canc Ctr, Dept Hematol & Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Winship Canc Ctr, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
D O I
10.1097/01243894-200602000-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:109 / 111
页数:3
相关论文
共 27 条
[1]  
Avizienyte E, 1998, CANCER RES, V58, P2087
[2]   LKB1 somatic mutations in sporadic tumors [J].
Avizienyte, E ;
Loukola, A ;
Roth, S ;
Hemminki, A ;
Tarkkanen, M ;
Salovaara, R ;
Arola, J ;
Bützow, R ;
Husgafvel-Pursiainen, K ;
Kokkola, A ;
Järvinen, H ;
Aaltonen, LA .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (03) :677-681
[3]   Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions [J].
Balsara, BR ;
Pei, JM ;
Mitsuuchi, Y ;
Page, R ;
Klein-Szanto, A ;
Wang, H ;
Unger, M ;
Testa, JR .
CARCINOGENESIS, 2004, 25 (11) :2053-2059
[4]   The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation [J].
Beuvink, I ;
Boulay, A ;
Fumagalli, S ;
Zilbermann, F ;
Ruetz, S ;
O'Reilly, T ;
Natt, F ;
Hall, J ;
Lane, HA ;
Thomas, G .
CELL, 2005, 120 (06) :747-759
[5]   The TOR pathway: A target for cancer therapy [J].
Bjornsti, MA ;
Houghton, PJ .
NATURE REVIEWS CANCER, 2004, 4 (05) :335-348
[6]   Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer [J].
Boffa, DJ ;
Luan, FL ;
Thomas, D ;
Yang, H ;
Sharma, VK ;
Lagman, M ;
Suthanthiran, M .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :293-300
[7]  
Brognard J, 2001, CANCER RES, V61, P3986
[8]   Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene [J].
Carretero, J ;
Medina, PP ;
Pio, R ;
Montuenga, LM ;
Sanchez-Cespedes, M .
ONCOGENE, 2004, 23 (22) :4037-4040
[9]   Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome [J].
Corradetti, MN ;
Inoki, K ;
Bardeesy, N ;
DePinho, RA ;
Guan, KL .
GENES & DEVELOPMENT, 2004, 18 (13) :1533-1538
[10]   Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage [J].
David, O ;
Jett, J ;
LeBeau, H ;
Dy, G ;
Hughes, J ;
Friedman, M ;
Brody, AR .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6865-6871